Prediction and analysis of Q-marker of Baogan jiangmei formula
- VernacularTitle:保肝降酶方质量标志物的预测分析
- Author:
Ying MENG
1
;
Yi HAN
1
;
Liyuan GAO
1
;
Xiang YANG
1
;
Xiaoyan CHANG
1
;
Jie LI
1
;
Chundi LIU
1
;
Siyiti MUKADAISI
2
;
Zhitao JIANG
1
Author Information
1. Dept. of Pharmacy,Zhangjiagang Hospital of Traditional Chinese Medicine,Jiangsu Zhangjiagang 215600,China
2. Dept. of Pharmacy,Gongliu County Hospital of Traditional Chinese Medicine,Xinjiang Ili,835400,China
- Publication Type:Journal Article
- Keywords:
Baogan jiangmei formula;
Fingerprint;
multicomponent content determination;
Network pharmacology;
Quality marker;
Drug-induced liver injury
- From:
China Pharmacy
2026;37(21):2802-2807
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To predict and analyze the quality marker(Q-Marker) of Baogan jiangmei formula.METHODS HPLC fingerprints of 15 batches of Baogan jiangmei formula were established, with common peaks identified against reference standards. The contents of characterized components were quantified by HPLC. Components absent in fingerprints were supplemented via TCMSP and literature retrieval. A component (11 identification components + 4 supplementary components)- disease (drug-induced liver injury) network was constructed using network pharmacology to predict the Q-Marker of Baogan jiangmei formula.RESULTS A total of 22 common peaks were identified in the HPLC fingerprints of 15 batches of samples, and 11 chromatographic peaks were identified, namely chlorogenic acid (peak 4), paeoniflorin (peak 9), polydatin (peak 10), neoastilobin (peak 11), astilobin (peak 12), neoisoastilbin (peak 14), isoastilbin (peak 15), resveratrol (peak 16), rosmarinic acid (peak 17), salvianolic acid B (peak 19), and ammonium glycyrrhizinate (peak 22). The contents of 11 components in 15 batches of Baogan jiangmei formula were 0.276 5-0.369 4, 1.218 4-1.623 1, 0.113 9-0.396 4, 0.252 8-0.822 5, 0.311 1-0.779 9, 0.273 6-0.752 9, 0.044 0-0.191 1, 0.013 1-0.047 7, 0.168 7-0.275 6, 0.763 9-1.993 8, 0.119 1-0.329 2 mg/g. Four components, namely isorhamnetin, curzerene, curdione and α -linolenic acid, were supplemented. Network pharmacology analysis showed that the 15 candidate components could interact with the disease targets. Functional enrichment mainly involved the response to exogenous stimulus, lipopolysaccharide response, protein kinase activity, transcription factor binding, nuclear receptor binding, etc. The enriched pathways primarily included the phosphoinositide 3-kinase/protein kinase B, tumor necrosis factor and hypoxia-inducible factor-1 signaling pathways.CONCLUSIONS Chlorogenic acid and the other 14 components are expected to be the Q-Markers of Baogan jiangmei formula for intervening in drug-induced liver injury.